Krystal Biotech to Present at Upcoming Investor Conferences
Krystal Biotech, Inc. KRYS
$306.89
▲ +0.13%
(+$0.39)
Open
$306.54
Prev Close
$306.50
Day Range
$303.59 – $308.09
52W Range
$192.52 – $382.54
Market Cap
$9.08B
P/E (TTM)
40.08
Beta
0.72
EPS (TTM)
$7.36
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-09-20 |
| Shares Out. | 29,600,000 |
| Website | krystalbio.com/ ↗ |
| Phone | 13026587581 |
Krystal Biotech, Inc. is a publicly traded company under the ticker symbol KRYS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
20 analysts (2026-11-01)
📰 Latest News for KRYS
Krystal Biotech, Inc. 2026 Q3 - Results - Earnings Call Presentation
Citigroup Maintains Buy on Krystal Biotech, Lowers Price Target to $412
TD Cowen Maintains Buy on Krystal Biotech, Lowers Price Target to $380
RBC Capital Maintains Outperform on Krystal Biotech, Lowers Price Target to $375
Krystal Biotech (KRYS) Stock Stays Above Fair Value After Buyback Plan
Earnings Beat May Change The Case For Krystal Biotech (KRYS) Stock
Is Krystal Biotech (KRYS) Undervalued On Earnings, Buybacks, And Vyjuvek Growth?